Horizon Oncology Center
Lafayette, Indiana 47906
0 studies enrolling now · 32 studies all time
What they study most
Advanced Cancer, Advanced Gastric Cancer, B Cell Non-Hodgkin's Lymphoma, B-Cell Lymphoma, Breast Cancer, Cancer, Chronic Lymphocytic Leukemia, Colorectal Cancer, ER, Esophageal Cancer, Estrogen Receptor Positive, Estrogen Receptor Positive Breast Cancer
Studies at this site
- Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer — Completed
- Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC — Completed
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) — Completed
- Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer — Status unconfirmed
- Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors — Status unconfirmed
- Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors — Completed
- A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas — Completed
- A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
- Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer — Completed
- A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer — Stopped early
- Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma — Completed
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia — Completed
- An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies — Stopped early
- Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes — Stopped early
- A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer — Stopped early
- Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole — Completed
- Sutent + Taxol for Advanced Esophageal Cancer — Completed
- Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer — Stopped early
- A Biological Sample Collection Protocol of Women With and Without Breast Cancer — Completed
- Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer — Stopped early
- Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer — Completed
- Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer — Stopped early
- Lonafarnib in Metastatic Breast Cancer — Stopped early
- Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer — Completed
- Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer — Completed
- A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer — Stopped early
- Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer — Completed
- Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer — Completed
- Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma — Completed
- A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer — Completed
- Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) — Status unconfirmed
- Study of EC0489 for the Treatment of Refractory or Metastatic Tumors — Completed